$1.09
0.03[2.83%]
At close: Apr 26
$1.09
0[0.00%]
After Hours: 7:36PM EDT
Adaptimmune Therapeutics
(NASDAQ:ADAP)Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Insider Trading Activity
Adaptimmune Therapeutics: Insider buying and selling updated today.
Shares Outstanding
255.562M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -39.384K | $0.70 | -$27.59K | SELL | -46.76% | 44.848K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | Elliot Norry | CHIEF MEDICAL OFFICER | -20.563K | $0.69 | -$14.11K | SELL | -51.64% | 19.257K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -22.795K | $0.70 | -$15.89K | SELL | -54.52% | 19.015K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | William Charles Bertrand | CHIEF OPERATING OFFICER | -23.589K | $0.70 | -$16.42K | SELL | -53.87% | 20.201K | Jan 16 - Jan 17 | View |
| Jan 12, 2024 | Elliot Norry | CHIEF MEDICAL OFFICER | -11.808K | $0.85 | -$10.02K | SELL | -49.93% | 11.841K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | William Charles Bertrand | CHIEF OPERATING OFFICER | -9.229K | $0.85 | -$7.81K | SELL | -53.96% | 7.874K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -29.202K | $0.85 | -$24.73K | SELL | -52.53% | 26.388K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -9.229K | $0.85 | -$7.81K | SELL | -53.96% | 7.874K | Jan 11 - Jan 12 | View |
| Sep 01, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.403K | $0.78 | -$1.87K | SELL | -41.06% | 3.449K | Sep 01 | View |
| Aug 01, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -3.096K | $0.91 | -$2.80K | SELL | -39.62% | 4.718K | Aug 01 | View |
| Jul 10, 2023 | Garry E Menzel | DIRECTOR | -47.702K | $0.91 | -$43.45K | SELL | -38.86% | 75.056K | Jul 10 | View |
| Jun 27, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.333K | $0.92 | -$2.15K | SELL | -39.87% | 3.519K | Jun 27 | View |
| Jan 31, 2023 | Cintia Piccina | CHIEF COMMERCIAL OFFICER | -11.89K | $1.87 | -$22.23K | SELL | -37.84% | 19.535K | Jan 31 | View |
| Jan 17, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.264K | Jan 17 | View |
| Jan 17, 2023 | William Charles Bertrand | CHIEF OPERATING OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.264K | Jan 17 | View |
| Jan 17, 2023 | Elliot Norry | CHIEF MEDICAL OFFICER | -2.159K | $1.86 | -$4.01K | SELL | -38.21% | 3.491K | Jan 17 | View |
| Jan 17, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -10.057K | $1.86 | -$18.69K | SELL | -42.96% | 13.351K | Jan 17 | View |
| Jan 12, 2023 | William Charles Bertrand | CHIEF OPERATING OFFICER | -8.816K | $1.72 | -$15.20K | SELL | -52.05% | 8.121K | Jan 11 - Jan 12 | View |
| Jan 12, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -8.816K | $1.72 | -$15.20K | SELL | -52.05% | 8.121K | Jan 11 - Jan 12 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.